Experimental Evaluation of Malathion-Induced Cytotoxicity and SOD1 Gene Expression in Triple-Negative Breast Cancer Cells
Experimed · 2026-10-02 · 0-0
DOI: 10.26650/experimed.1895536 ↗Abstract
Objective: This study aimed to investigate the cytotoxic effects of the organophosphate pesticide malathion on triple-negative breast cancer (TNBC) cells and to examine its impact on superoxide dismutase 1 (SOD1) gene expression.Materials and Methods: Human MDA-MB-231 TNBC cells were treated with escalating concentrations of malathion. Cell viability was assessed using the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay, and the half-maximal inhibitory concentration (IC₅₀) was determined. Wound healing and matrigel transwell invasion assays were performed to evaluate cell migration and invasive capacity, respectively. Following exposure to the IC₅₀ concentration for 24 and 48 hours, SOD1 mRNA levels were measured via real-time quantitative polymerase chain reaction (RT-qPCR). Molecular docking analyses were performed using AutoDock and SeamDock to assess interactions between malathion and the human SOD1 protein (PDB ID: 2NAM).Results: Malathion reduced cell viability in a dose-dependent manner, with an IC₅₀ value of 17.79 μM after 48 hours of exposure. Treatment at this concentration significantly reduced both migratory activity (p
EUVIMED